Alzheimer's Disease Cooperative Study (ADCS)
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Alzheimer's Disease Cooperative Study (ADCS) sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Alzheimer's Disease Cooperative Study (ADCS): 10 sponsored US clinical trials, 1 recruiting.
Alzheimer's Disease Cooperative Study (ADCS) sponsors 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 9 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimers Disease, with 2 trials.
Top-decile sponsor footprint
Alzheimer's Disease Cooperative Study (ADCS) ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
NCT06223360
"Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program"
NCT05350410
Prazosin for Agitation in Alzheimer's Disease
NCT03710642
Exercise in Adults With Mild Memory Problems
NCT02814526
Resveratrol for Alzheimer's Disease
NCT01504854
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
NCT01078636
Home-Based Assessment for Alzheimer Disease Prevention
NCT00546767
DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
NCT00440050
ADNI: Alzheimer's Disease Neuroimaging Initiative
NCT00106899
Valproate in Dementia (VALID)
NCT00071721
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
What is open in the Alzheimer's Disease Cooperative Study (ADCS) pipeline
1 recruiting of 10 indexed (10% open); 9 completed (90%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Alzheimers Disease (2 trials), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Alzheimer's Disease Cooperative Study (ADCS): open-pipeline peers nationwide
Peers matched on 10 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Alzheimer's Disease Cooperative Study (ADCS) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Abiomed · 10% recruiting · 20 trials
- Aimmune Therapeutics · 10% recruiting · 10 trials
- Altria Client Services · 10% recruiting · 10 trials
- Ascension Health · 10% recruiting · 10 trials
Related
What to do with this Alzheimer's Disease Cooperative Study (ADCS) page
10 registered trials is a research-attention snapshot, not an endorsement of Alzheimer's Disease Cooperative Study (ADCS) or any single study.
- 1 of Alzheimer's Disease Cooperative Study (ADCS)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimers Disease is the condition Alzheimer's Disease Cooperative Study (ADCS) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimers Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Alzheimer's Disease Cooperative Study (ADCS) pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.